Pfizer (PFE) P/E (2009 - 2026)
Pfizer (PFE) P/E from Jun 29, 2009 to Jul 20, 2026. The TTM Pfizer (PFE) P/E is 11.62. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Pfizer (PFE)
| Year | P/E | Change |
|---|---|---|
| 2026 | 11.62 | +14.13% |
| 2025 | 10.18 | -64.54% |
| 2024 | 28.72 | +150.29% |
| 2023 | 11.47 | +37.90% |
| 2022 | 8.32 | -49.51% |
| 2021 | 16.48 | +29.03% |
| 2020 | 12.77 | +26.48% |
| 2019 | 10.10 | -40.63% |
| 2018 | 17.01 | -14.09% |
| 2017 | 19.79 | -10.07% |
| 2016 | 22.01 | +13.26% |
| 2015 | 19.43 | +7.61% |
| 2014 | 18.06 | +99.42% |
| 2013 | 9.06 | -39.65% |
| 2012 | 15.01 | -12.38% |
| 2011 | 17.13 | +8.43% |
| 2010 | 15.80 | -37.08% |
| 2009 | 25.10 | N/A |
Comparison Pfizer (PFE) P/E with competitors
Pfizer (PFE) P/E is 11.62.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -13.01% |
| NVO | Novo Nordisk | 11.79 | +1.46% |
| GSK | GSK Plc | 12.10 | +4.15% |
| SNY | Sanofi | 12.12 | +4.33% |
| BMY | Bristol-Myers Squibb Company | 13.82 | +18.92% |
| OGN | Organon & Company | 14.33 | +23.28% |
| BIIB | Biogen Inc | 17.41 | +49.77% |
| GILD | Gilead Sciences Inc | 17.75 | +52.70% |
| NVS | Novartis AG | 21.60 | +85.84% |
| JNJ | Johnson & Johnson | 22.09 | +90.07% |
| AMGN | AMGEN Inc | 24.75 | +112.98% |
| MRK | Merck & Co Inc | 26.93 | +131.71% |
| AZN | Astrazeneca plc | 28.44 | +144.75% |
| LLY | Lilly(Eli) & Company | 48.44 | +316.85% |
| ABBV | Abbvie Inc | 139.08 | +1096.79% |